Boston Scientific Co. (NYSE:BSX) is Rhenman & Partners Asset Management AB's 4th Largest Position

Rhenman & Partners Asset Management AB lessened its holdings in Boston Scientific Co. (NYSE:BSX – Free Report) by 3.3% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 580,000 shares of the medical equipment provider’s stock after selling 20,000 shares during the […]

Related Keywords

Canada ,Boston ,Massachusetts ,United States ,Michaelf Mahoney ,Raymond James ,Jeffreyb Mirviss ,Boston Scientific Co ,Securities Exchange Commission ,Investors Pty Ltd ,Needham Company ,Boston Scientific ,Canaccord Genuity Group ,Boston Scientific Corporation ,Transcend Capital Advisors ,National Bank ,Intact Investment Management Inc ,Exchange Commission ,Partners Asset Management ,Free Report ,Capital Advisors ,Pty Ltd ,Intact Investment Management ,Investment Management ,Genuity Group ,Get Free Report ,Scientific Corporation ,Visit Holdingschannel ,Boston Scientific Daily ,Nyse Bsx ,Bsx ,Medical ,10113710 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,